About AgeChem Venture Fund

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.

Investment Details

Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
VR/AR
Investor Type
Venture Capital

Investment Focus

Focus Areas
VR/AR
Investment Stages
Early Stage Venture, Late Stage Venture